Inventor
Weiyong KONG
Inventor
CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07DHeterocyclic compounds17%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture17%
Y02PClimate change mitigation technologies in the production or processing of goods11%
C07BGeneral methods of organic chemistry6%
C07KPeptides6%
C11DDetergent compositions6%
C12NMicroorganisms or enzymes6%
PatentTitleYear
11,654,144Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1- yl)pyrimidin-4-amine and new salts202311,578,053Chemical process for preparing phenylpiperidinyl indole derivatives202311,220,681Enzymatic reaction medium containing surfactant202211,208,398Chemical process for preparing phenylpiperidinyl indole derivatives2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to NOVARTIS AG (4)· patent assignee history
2021–2023Based in CN· patent location history
2023Patents assigned to PALOBIOFARMA SL (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 4 | 2021–2023 |
| PALOBIOFARMA SL | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 4 | 2021–2023 |